Jailani, Baby Boy .
HRN: 22-75-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2023
MUPIROCIN 2%, 15G (TUBE)
03/24/2023
03/30/2023
TOPICAL
-
TID
Post IV Site Infection
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes